| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,892 | 13,591 | 14,268 | 15,214 | | Cost of Revenue | 4,727 | 5,231 | 5,593 | 6,150 | | | Gross Profit |
-
| 8,360 | 8,675 | 9,064 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,249 | 5,708 | 4,546 | 4,485 | | Non Recurring | 731 |
-
|
-
|
-
| | Others | 8,884 | 12,490 | 4,570 | 3,116 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (9,838) | (441) | 1,463 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (5,699) | (9,838) | (441) | 1,463 | | Interest Expense | 1,569 | 1,646 | 1,618 | 1,832 | | Income Before Tax | (7,268) | (11,484) | (2,059) | (369) | | Income Tax Expense | (2,909) | (4,611) | (714) | (139) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,359) | (6,873) | (1,345) | (230) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,359) | (6,873) | (1,345) | (230) | | Preferred Stock And Other Adjustments | (431) | (413) | (427) | (194) | | | Net Income Applicable To Common Shares | ($4,790) | ($7,286) | ($1,772) | ($424) |
|
0.01% Nasdaq 0.00%
Income Statement
